Get 20% Free Customization In This Report

Buy this report from - $3456

Microtome Market by Product (Microtome Devices and Accessories), by Technology (Fully Automated, Semi-automated, and Manual), and by End User (Hospitals, ASCs, and Research Centers) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI_184494	Pages: NA	Jun 2018 \| 164 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Microtome is a tool, which is used to cut thin sections from the tissue sample of plants or animals. The tool uses special blades made up of metal, glass, or diamond depending on the type of specimen and the desired thickness.

Growth in awareness about the early diagnosis of various chronic diseases and introduction of technologically advanced diagnostic equipment and pathological systems drive the market. In addition, increase in incidence of chronic disease such as cancer coupled with rise in geriatric population further stimulates the market growth. However, unfavorable reimbursement scenario restricts the market growth.

The global microtome market is segmented on the basis of product, technology, end user, and region. According to product type, the market is bifurcated into microtome devices and accessories. By technology, the market is divided into fully automated, semi-automated, and manual. On the basis of end user, the market is classified into hospitals, ASCs, research centers, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies of the microtome market include LLS ROWIAK LaserLabSolutions GmbH, Leica Biosystems Nussloch GmbH, Sakura Finetek Europe B.V, MEDITE GmbH, SLEE medical GmbH, Boeckeler Instruments, Nanolytik, S.M. Scientific Instruments Pvt. Ltd., Amos Scientific Pty Ltd., and AGD Biomedicals.

Key Benefits

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market assists in understanding the regional trends.
Key players and their strategies are analyzed to understand the competitive outlook of the market.

Microtome Market Key Segments:

By Product

Microtome Devices
Accessories

By Technology

Fully Automated
Semi-automated
Manual

By End User

Hospitals
ASCs
Research Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Porters Five Forces Analysis
3.3 Market Share Analysis, 2016
3.4 Market Dynamics

3.4.1 Drivers
3.4.2 Restraints
3.4.3 Opportunities

Chapter: 4 MICROTOME MARKET, BY PRODUCT

4.1 Overview
4.2 Market size and forecast
4.3 Microtome Devices

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Accessories

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

Chapter: 5 MICROTOME MARKET, BY TECHNOLOGY

5.1 Overview
5.2 Market size and forecast
5.3 Fully Automated

5.3.1 Market size and forecast

5.4 Semi-automated

5.4.1 Market size and forecast

5.5 Manual

5.5.1 Market size and forecast

Chapter: 6 MICROTOME MARKET, BY END USER

6.1 Overview
6.2 Market size and forecast
6.3 Hospitals

6.3.1 Market size and forecast

6.4 ASCs

6.4.1 Market size and forecast

6.5 Research Centers

6.5.1 Market size and forecast

6.6 Others

6.6.1 Market size and forecast

Chapter: 7 MICROTOME MARKET, BY REGION

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.2.3.1 U.S. market size and forecast
7.2.3.2 Canada market size and forecast
7.2.3.3 Mexico market size and forecast
7.2.3.4 North America microtome market by product
7.2.3.5 North America microtome market by technology
7.2.3.6 North America microtome market by end user

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.3.3.1 Germany market size and forecast
7.3.3.2 France market size and forecast
7.3.3.3 UK market size and forecast
7.3.3.4 Italy market size and forecast
7.3.3.5 Spain market size and forecast
7.3.3.6 Rest of Europe market size and forecast
7.3.3.7 Europe microtome market by product
7.3.3.8 Europe microtome market by technology
7.3.3.9 Europe microtome market by end user

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.4.3.1 Japan market size and forecast
7.4.3.2 China market size and forecast
7.4.3.3 India market size and forecast
7.4.3.4 Australia market size and forecast
7.4.3.5 Rest of Asia-Pacific market size and forecast
7.4.3.6 Asia-Pacific microtome market by product
7.4.3.7 Asia-Pacific microtome market by technology
7.4.3.8 Asia-Pacific microtome market by end user

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

7.5.3.1 Brazil market size and forecast
7.5.3.2 South Africa market size and forecast
7.5.3.3 Saudi Arabia market size and forecast
7.5.3.4 Rest of LAMEA market size and forecast
7.5.3.5 LAMEA microtome market by product
7.5.3.6 LAMEA microtome market by technology
7.5.3.7 LAMEA microtome market by end user

Chapter: 8 COMPANY PROFILES

8.1 LLS ROWIAK LaserLabSolutions GmbH

8.1.1 Overview
8.1.2 Company snapshot
8.1.3 Business performance
8.1.4 Operating segment overview
8.1.5 Strategic moves and developments

8.2 Leica Biosystems Nussloch GmbH

8.2.1 Overview
8.2.2 Company snapshot
8.2.3 Business performance
8.2.4 Operating segment overview
8.2.5 Strategic moves and developments

8.3 Sakura Finetek Europe B.V

8.3.1 Overview
8.3.2 Company snapshot
8.3.3 Business performance
8.3.4 Operating segment overview
8.3.5 Strategic moves and developments

8.4 MEDITE GmbH

8.4.1 Overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Operating segment overview
8.4.5 Strategic moves and developments

8.5 SLEE medical GmbH

8.5.1 Overview
8.5.2 Company snapshot
8.5.3 Business performance
8.5.4 Operating segment overview
8.5.5 Strategic moves and developments

8.6 Boeckeler Instruments

8.6.1 Overview
8.6.2 Company snapshot
8.6.3 Business performance
8.6.4 Operating segment overview
8.6.5 Strategic moves and developments

8.7 Nanolytik

8.7.1 Overview
8.7.2 Company snapshot
8.7.3 Business performance
8.7.4 Operating segment overview
8.7.5 Strategic moves and developments

8.8 S.M. Scientific Instruments Pvt. Ltd.

8.8.1 Overview
8.8.2 Company snapshot
8.8.3 Business performance
8.8.4 Operating segment overview
8.8.5 Strategic moves and developments

8.9 Amos Scientific Pty Ltd.

8.9.1 Overview
8.9.2 Company snapshot
8.9.3 Business performance
8.9.4 Operating segment overview
8.9.5 Strategic moves and developments

8.10 AGD Biomedicals

8.10.1 Overview
8.10.2 Company snapshot
8.10.3 Business performance
8.10.4 Operating segment overview
8.10.5 Strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Microtome Market by Product (Microtome Devices and Accessories), by Technology (Fully Automated, Semi-automated, and Manual), and by End User (Hospitals, ASCs, and Research Centers) - Global Opportunity Analysis and Industry Forecast, 2017-2023